JP2012510502A5 - - Google Patents

Download PDF

Info

Publication number
JP2012510502A5
JP2012510502A5 JP2011538999A JP2011538999A JP2012510502A5 JP 2012510502 A5 JP2012510502 A5 JP 2012510502A5 JP 2011538999 A JP2011538999 A JP 2011538999A JP 2011538999 A JP2011538999 A JP 2011538999A JP 2012510502 A5 JP2012510502 A5 JP 2012510502A5
Authority
JP
Japan
Prior art keywords
compound
formula
pyrrolidine
compound represented
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2011538999A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012510502A (ja
Filing date
Publication date
Priority claimed from EP08170435A external-priority patent/EP2194048A1/en
Application filed filed Critical
Publication of JP2012510502A publication Critical patent/JP2012510502A/ja
Publication of JP2012510502A5 publication Critical patent/JP2012510502A5/ja
Ceased legal-status Critical Current

Links

JP2011538999A 2008-12-02 2009-12-01 血管性及び代謝性疾患の処置のためのシロスタゾールの硝酸エステル誘導体 Ceased JP2012510502A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08170435.5 2008-12-02
EP08170435A EP2194048A1 (en) 2008-12-02 2008-12-02 Nitrate esters for the treatment of vascular and metabolic diseases
PCT/EP2009/066159 WO2010063724A1 (en) 2008-12-02 2009-12-01 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases

Publications (2)

Publication Number Publication Date
JP2012510502A JP2012510502A (ja) 2012-05-10
JP2012510502A5 true JP2012510502A5 (https=) 2013-01-24

Family

ID=40456966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011538999A Ceased JP2012510502A (ja) 2008-12-02 2009-12-01 血管性及び代謝性疾患の処置のためのシロスタゾールの硝酸エステル誘導体

Country Status (14)

Country Link
US (1) US8426597B2 (https=)
EP (2) EP2194048A1 (https=)
JP (1) JP2012510502A (https=)
KR (1) KR20110088598A (https=)
CN (1) CN102245583A (https=)
AU (1) AU2009324123A1 (https=)
BR (1) BRPI0923300A2 (https=)
CA (1) CA2745252A1 (https=)
IL (1) IL213214A0 (https=)
MX (1) MX2011005744A (https=)
RU (1) RU2011126607A (https=)
SG (1) SG171423A1 (https=)
WO (1) WO2010063724A1 (https=)
ZA (1) ZA201104011B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011131613A1 (en) 2010-04-19 2011-10-27 Cardiolynx Ag Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases
AR081268A1 (es) 2010-06-02 2012-07-18 Cardiolynx Ag Derivados de nitrato de pioglitazona
ES2691092T3 (es) 2012-08-21 2018-11-23 Janssen Pharmaceutica Nv Anticuerpos contra la risperidona y uso de los mismos
CN104837838A (zh) 2012-08-21 2015-08-12 詹森药业有限公司 帕潘立酮半抗原
PL2888592T3 (pl) 2012-08-21 2018-03-30 Janssen Pharmaceutica Nv Przeciwciała względem kwetiapiny i ich zastosowania
CA2882596C (en) 2012-08-21 2019-05-14 Ortho-Clinical Diagnostics, Inc. Antibodies to olanzapine and use thereof
WO2014031656A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to olanzapine haptens and use thereof
JP6131414B2 (ja) 2012-08-21 2017-05-24 ヤンセン ファーマシューティカ エヌ.ベー. アリピプラゾールのハプテン及びイムノアッセイにおけるそれらの使用
CA2882562C (en) 2012-08-21 2019-08-27 Eric Hryhorenko Antibodies to aripiprazole and use thereof
JP2015527365A (ja) 2012-08-21 2015-09-17 オルソ−クリニカル ダイアグノスティクス,インコーポレイティド パリペリドンに対する抗体及びその使用
ES2669565T3 (es) 2012-08-21 2018-05-28 Janssen Pharmaceutica Nv Haptenos de risperidona y paliperidona
PL2888257T3 (pl) 2012-08-21 2018-02-28 Janssen Pharmaceutica Nv Hapteny kwetiapiny do zastosowania w testach immunologicznych
JP2015529199A (ja) 2012-08-21 2015-10-05 オルソ−クリニカル ダイアグノスティクス,インコーポレイティド パリペリドンハプテンに対する抗体及びその使用
CN104854110B (zh) 2012-08-21 2016-12-28 詹森药业有限公司 奥氮平半抗原
EP2888284B1 (en) 2012-08-21 2022-07-06 Janssen Pharmaceutica NV Antibodies to risperidone haptens and use thereof
JP6389176B2 (ja) 2012-08-21 2018-09-12 ヤンセン ファーマシューティカ エヌ.ベー. アリピプラゾールハプテンに対する抗体及びその使用
JP6450314B2 (ja) 2012-08-21 2019-01-09 ヤンセン ファーマシューティカ エヌ.ベー. クエチアピンハプテンに対する抗体及びその使用
EP3390449A1 (en) 2015-12-17 2018-10-24 Janssen Pharmaceutica N.V. Antibodies to risperidone and use thereof
US10435478B2 (en) 2015-12-17 2019-10-08 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof
CN114044766B (zh) * 2021-10-09 2022-12-27 张北北九食品检验技术有限公司 放射性同位素碳-14标记的呋虫胺和中间体及其制备方法和应用
CN120441542B (zh) * 2025-05-08 2025-09-30 安徽益普克医药科技发展有限公司 一种西洛他唑衍生物及其制备方法与用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535019A (en) 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
DE122007000050I1 (de) 1990-02-19 2007-11-08 Novartis Ag Acylverbindungen
US6148496A (en) 1999-04-09 2000-11-21 The Procter & Gamble Company Method for making a seamless apertured metal belt
IT1311924B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
PL379420A1 (pl) 2003-07-31 2006-09-04 Nicox S.A. Pochodne blokerów receptora angiotensyny II
WO2006079610A1 (en) * 2005-01-31 2006-08-03 Nicox S.A. Nitrooxy sartan derivatives as angiotensin ii receptor blockers for the treatment of cardiovascular and inflammatory diseases
EP1922069A2 (en) * 2005-08-08 2008-05-21 Nitromed, Inc. Nitric oxide enhancing angiotensin ii antagonist compounds, compositions and methods of use

Similar Documents

Publication Publication Date Title
JP2012510502A5 (https=)
JP2009534398A5 (https=)
JP2005053931A5 (https=)
JP2010529961A5 (https=)
RU2011126607A (ru) Нитратные производные цилостазола для лечения сосудистых заболеваний и нарушений обмена веществ
JP2009534471A5 (https=)
JP2018511590A5 (https=)
JP2009533410A5 (https=)
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
JP2011513410A5 (https=)
JP2009530306A5 (https=)
JP2006524222A5 (https=)
JP2009535356A5 (https=)
JP2006514626A5 (https=)
JP2008500999A5 (https=)
JP2011512412A5 (https=)
JP2014504646A5 (https=)
JP2009538336A5 (https=)
NO20082747L (no) Arylisoksazol-4-yl-imidazolderivater
JP2008546770A5 (https=)
JP2010520214A5 (https=)
JP2014505723A5 (https=)
JP2018530582A5 (https=)
JP2010526801A5 (https=)
JP2005517643A5 (https=)